Raphael Pharmaceutical Inc.
RAPH· OTC
RAPHRaphael Pharmaceutical Inc.
Filed May 16, 2022 · 10-Q · 46 days after period end · 0001213900-22-026790
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Net Income | -$185.00K | -$255.00K |
| EPS Diluted | $0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Raphael Pharmaceutical Inc. · CIK 1415397 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 16, 2022 · 46 d after period end
